Expression and release of HLA-E by melanoma cells and melanocytes: Potential impact on the response of cytotoxic effector cells

Journal of Immunology

Volumn 177, Issue 5, 2006, Pages 3100-3107

  Derré, Laurent ^a   Corvaisier, Murielle ^a   Charreau, Béatrice ^a   Moreau, Anne ^b   Godefroy, Emmanuelle ^a   Moreau Aubry, Agnès ^a,c   Jotereau, Francine ^a,c   Gervois, Nadine ^a,c  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; GAMMA INTERFERON; HLA E ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; METALLOPROTEINASE; NATURAL KILLER CELL RECEPTOR NKG2A;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOLOGY; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBIOLOGY; INTRACELLULAR SPACE; MELANOCYTE; MELANOMA CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TUMOR BIOPSY;

EID: 33747793367     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.5.3100     Document Type: Article

References (57)

1. Pamer, E., and P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Amu. Rev. Immunol. 16: 323-358.
2. 2-microglobulin and allelic differences. Eur. J. Immunol. 29: 537-547.
3. Ulbrecht, M., J. Kellermann, J. P. Johnson, and E. H. Weiss. 1992. Impaired intracellular transport and cell surface expression of nonpolymorphic HLA-E: evidence for inefficient peptide binding. J. Exp. Med. 176: 1083-1090.
4. Braud, V., E. Y. Jones, and A. McMichael. 1997. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27: 1164-1169.
5. Michaelsson, J., C. Teixeira de Matos, A. Achour, L. L. Lanier, K. Karre, and K. Soderstrom. 2002. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J. Exp. Med. 196: 1403-1414.
6. Wooden, S. L., S. R. Kalb, R. J. Cotter, and M. J. Soloski. 2005. Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis. J. Immunol. 175: 1383-1387.
7. + T cells. J. Exp. Med. 196: 1473-1481.
8. Mazzarino, P., G. Pietra, P. Vacca, M. Falco, D. Colau, P. Coulie, L. Moretta, and M. C. Mingari. 2005. Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion. Eur. J. Immunol. 35: 3240-3247.
9. 2- adrenoreceptor variants with bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 161: 469-474.
10. Braud, V. M., D. S. Allan, C. A. O'Callaghan, K. Soderstrom, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799.
11. Brooks, A. G., F. Borrego, P. E. Posch, A. Patamawenu, C. J. Scorzelli, M. Ulbrecht, E. H. Weiss, and J. E. Coligan. 1999. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J. Immunol. 162: 305-313.
12. Lee, N., M. Llano, M. Carretero, A. Ishitani, F. Navarro, M. Lopez-Botet, and D. E. Geraghty. 1998. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95: 5199-5204.
13. Llano, M., N. Lee, F. Navarro, P. Garcia, J. P. Albar, D. E. Geraghty, and M. Lopez-Botet. 1998. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 28: 2854-2863.
14. Tomasec, P., V. M. Braud, C. Rickards, M. B. Powell, B. P. McSharry, S. Gadola, V. Cerundolo, L. K. Borysiewicz, A. J. McMichael, and G. W. Wilkinson. 2000. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287: 1031.
15. Romagnani, C., G. Pietra, M. Falco, E. Millo, P. Mazzarino, R. Biassoni, A. Moretta, L. Moretta, and M. C. Mingari. 2002. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc. Natl. Acad. Sci. USA 99: 11328-11333.
16. Borrego, F., M. Ulbrecht, E. H. Weiss, J. E. Coligan, and A. G. Brooks. 1998. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187: 813-818.
17. + T cells. Trends Immunol. 24: 162-164.
18. Le Drean, E., F. Vely, L. Olcese, A. Cambiaggi, S. Guia, G. Krystal, N. Gervois, A. Moretta, F. Jotereau, and E. Vivier. 1998. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur. J. Immunol. 28: 264-276.
19. Garcia, P., M. Llano, A. B. de Heredia, C. B. Willberg, E. Caparros, P. Aparicio, V. M. Braud, and M. Lopez-Botet. 2002. Human T cell receptor-mediated recognition of HLA-E. Eur. J. Immunol. 32: 936-944.
20. Hu, D., K. Ikizawa, L. Lu, M. E. Sanchirico, M. L. Shinohara, and H. Cantor. 2004. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immunol. 5: 516-523.
21. + T cell mediated regulatory pathway. Cell Mol. Immunol. 2: 161-167.
22. + T cells restricted by the MHC class 1b molecule, Qa-1. Annu. Rev. Immunol. 18: 185-216.
23. + T cells expressing Vβ8 TCR: a role of the Qa-1 molecule. Immunity 2: 185-194.
24. Jiang, H., Y. Wu, B. Liang, Z. Zheng, G. Tang, J. Kanellopoulos, M. Soloski, R. Winchester, I. Goldstein, and L. Chess. 2005. An affinity/avidity model of peripheral T cell regulation. J. Clin. Invest. 115: 302-312.
25. + CTLs by TCR Vβ-derived peptides bound to HLA-E. J. Immunol. 167: 3800-3808.
26. + T cells. Immunity 2: 177-184.
27. Malmberg, K. J., V. Levitsky, H. Norell, C. T. de Matos, M. Carlsten, K. Schedvins, H. Rabbani, A. Moretta, K. Soderstrom, J. Levitskaya, and R. Kiessling. 2002. IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J. Clin. Invest. 110: 1515-1523.
28. Speiser, D. E., M. J. Pittet, D. Valmori, R. Dunbar, D. Rimoldi, D. Lienard, H. R. MacDonald, J. C. Cerottini, V. Cerundolo, and P. Romero. 1999. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J. Exp. Med. 190: 775-782.
29. Marin, R., F. Ruiz-Cabello, S. Pedrinaci, R. Mendez, P. Jimenez, D. E. Geraghty, and F. Garrido. 2003. Analysis of HLA-E expression in human tumors. Immunogenetics 54: 767-775.
30. Palmisano, G. L., E. Contardi, A. Morabito, V. Gargaglione, G. B. Ferrara, and M. P. Pistillo. 2005. HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines. Hum. Immunol. 66: 1-12.
31. Menier, C., B. Saez, V. Horejsi, S. Martinozzi, I. Krawice-Radanne, S. Bruel, C. Le Danff, M. Reboul, I. Hilgert, M. Rabreau, et al. 2003. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum. Immunol. 64: 315-326.
32. Regnier, M., C. Duval, J. B. Galey, M. Philippe, A. Lagrange, R. Tuloup, and R. Schmidt. 1999. Keratinocyte-melanocyte co-cultures and pigmented reconstructed human epidermis: models to study modulation of melanogenesis. Cell. Mol. Biol. 45: 969-980.
33. + cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements. Eur. J. Immunol. 20: 825-831.
34. Geryois, N., Y. Guilloux, E. Diez, and F. Jotereau. 1996. Suboptimal activation of melanoma infiltrating lymphocytes (TTL) due to low avidity of TCR/MHC-tumor peptide interactions. J. Exp. Med 183: 2403-2407.
35. Gervois, N., N. Labarriere, S. Le Guiner, M. C. Pandolfino, J. F. Fonteneau, Y., Guilloux, E. Diez, B. Dreno, and F. Jotereau. 2000. High avidity melanoma-reactiye cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocyctes on stimulation by peptide-pulsed melanoma cells. Clin. Cancer Res. 6: 1459-1467.
36. Jotereau, F., M. C. Pandolfino, D. Boudart, E. Diez, B. Dreno, J. Y. Douillard, J. Y. Muller, and B. LeMevel. 1991. High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy. J. Immunother. 10: 405-411.
37. Maier, S., M. Grzeschik, E. H. Weiss, and M. Ulbrecht. 2000. Implications of HLA-E allele expression and different HLA-E ligand diversity for the regulation of NK cells. Hum. Immunol. 61: 1059-1065.
38. Strong, R. K., M. A. Holmes, P. Li, L. Braun, N. Lee, and D. E. Geraghty. 2003. HLA-E allelic variants: correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J. Biol. Chem. 278: 5082-5090.
39. Groh, V., J. Wu, C. Yee, and T. Spies. 2002. Tumor-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419: 734-738.
40. Ugurel, S., V. Rebmann, S. Ferrone, W. Tilgen, H. Grosse-Wilde, and U. Reinhold. 2001. Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-α immunotherapy. Cancer 92: 369-376.
41. 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. J. Biol. Chem. 269: 6689-6694.
42. Dong, Y., J. Lieskovska, D. Kedrin, S. Porcelli, O. Mandelboim, and Y. Bushkin. 2003. Soluble nonclassical HLA generated by the metalloproteinase pathway. Hum. Immunol. 64: 802-810.
43. Park, G. M., S. Lee, B. Park, E. Kim, J. Shin, K. Cho, and K. Ahn. 2004. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis. Biochem. Biophys. Res. Commun. 313: 606-611.
44. + suppressor T cells. J. Clin. Invest. 114: 1218-1221.
45. Lu, Y., W. Y. Zhu, C. Tan, G. H. Yu, and J. X. Gu. 2002. Melanocytes are potential immunocompetent cells: evidence from recognition of immunological characteristics of cultured human melanocytes. Pigm. Cell. Res. 15: 454-460.
46. Miller, J. D., D. A. Weber, C. Ibegbu, J. Pohl, J. D. Altman, and P. E. Jensen. 2003. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. J. Immunol. 171: 1369-1375.
47. Groh, V., S. Bahrain, S. Bauer, A. Herman, M. Beauchamp, and T. Spies. 1996. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 93: 12445-12450.
48. Paul, P., N. Rouas-Freiss, P. Moreau, F. A. Cabestre, C. Menier, I. Khalil-Daher, C. Pangault, M. Onno, R. Fauchet, J. Martinez-Laso, et al. 2000. HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression. Hum. Immunol. 61: 1177-1195.
49. Barrett, D. M., K. S. Gustafson, J. Wang, S. Z. Wang, and G. D. Cinder. 2004. A GATA factor mediates cell type-restricted induction of HLA-E gene transcription by γ Interferon. Mol. Cell. Biol. 24: 6194-6204.
50. Gobin, S. J., and P. J. van den Elsen. 2000. Transcriptional regulation of the MHC class Ib genes HlA-E, HLA-F, and HLA-G. Hum. Immunol. 61: 1102-1107.
51. Algarra, I., A. Garcia-Lora, T. Cabrera, F. Ruiz-Cabello, and F. Garrido. 2004. The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape. Cancer Immunol. Immunother. 53: 904-910.
52. Bubenik, J. 2004. MHC class I down-regulation: tumor escape from immune surveillance? Int. J. Oncol. 25: 487-491.
53. Demaria, S., and Y. Bushkin. 2000. Soluble HLA proteins with bound peptides are released from the cell surface by the membrane metalloproteinase. Hum. Immunol. 61: 1332-1338.
54. Dobbe, L. M., N. J. Stam, J. J. Neefjes, and M. J. Giphart. 1988. Biochemical complexity of serum HLA class I molecules. Immunogenetics 27: 203-210.
55. Chu, S. C., D. N. Hu, S. F. Yang, P. Y. Yang, Y. S. Hsieh, S. M. Huang, G. Yu, and S. A. McCormick. 2004. Uveal melanocytes produce matrix metalloproteinases-2 and -9 in vitro. Pigm. Cell. Res. 17: 636-642.
56. Lopez-Botet, M., and T. Bellon. 1999. Natural killer cell activation and inhibition by receptors for MHC class I. Curr. Opin. Immunol. 11: 301-307.
57. Paust, S., and H. Cantor. 2005. Regulatory T cells and autoimmune disease. Immunol. Rev. 204: 195-207.